tiprankstipranks
LakeShore Biopharma (LSB)
NASDAQ:LSB
US Market

LakeShore Biopharma (LSB) Income Statement

Compare
85 Followers

LakeShore Biopharma Income Statement

Last quarter (Q3 2024), LakeShore Biopharma's total revenue was ¥168.71M, a decrease of -13.39% from the same quarter last year. In Q3, LakeShore Biopharma's net income was ¥-80.15M. See LakeShore Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 573.42M¥ 687.20M¥ 502.95M¥ 257.02M
Gross Profit
¥ 455.73M¥ 533.84M¥ 385.88M¥ 197.36M
Operating Expenses
¥ 901.56M¥ 647.15M¥ 549.18K¥ 319.68M
Depreciation and Amortization
¥ 42.19M¥ 36.69M¥ 31.15M¥ 27.91M
EBITDA
¥ -368.66M¥ -76.80M¥ -67.20M¥ -116.78M
Operating Income
¥ -445.83M¥ -139.38M¥ -549.18K¥ -125.85M
Other Income/Expenses
¥ -9.36M¥ -4.96M¥ 17.89M¥ -48.52M
Pretax Income
¥ -455.19M¥ -144.35M¥ -545.73K¥ -174.37M
Net Income
¥ -433.46M¥ -145.48M¥ -545.73K¥ -191.83M
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ -4.05¥ -1.88¥ -0.02¥ -6.67
Diluted EPS
¥ -4.05¥ -1.88¥ -0.02¥ -6.67
Weighted Average Shares Outstanding
106.92M 77.42M 29.50M 28.75M
Weighted Average Shares Outstanding (Diluted)
106.92M 77.42M 29.50M 28.75M
Currency in CNY

LakeShore Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis